Cabaletta Bio (CABA) Other financing activities (2019)

Cabaletta Bio (CABA) recorded quarterly Other financing activities of $1.3 million in Q1 2019.

Cabaletta Bio (CABA) Other financing activities (2019) Analysis & Trends

Cabaletta Bio's Other financing activities history runs 1 years deep, the most recent figure standing at $1.3 million for Q1 2019.

In Q1 2019, Other financing activities changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2019 stood at $1.3 million (changed N/A YoY), while the FY2019 annual figure was $1.3 million, up 665.09% from the prior year.
Other financing activities was $1.3 million for Q1 2019 at Cabaletta Bio.
In the past five years, Other financing activities ranged from a high of $1.3 million in Q1 2019 to a low of $1.3 million in Q1 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Cabaletta Bio	151.84 Mn	18.24 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2019	1.29 Mn
Mar 31, 2019	1.29 Mn